Gsb Wealth Management, LLC Novo Nordisk A S Transaction History

Gsb Wealth Management, LLC

$387 Million
Q3 2024

A detailed history of Gsb Wealth Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Gsb Wealth Management, LLC holds 12,424 shares of NVO stock, worth $1.28 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

12,424

Previous 13,628 8.83%

Holding current value

$1.28 Million

Previous $1.95 Million 23.96%

% of portfolio

0.38%

Previous 0.54%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$119.07 - $145.42 $143,360 - $175,085	-1,204 Reduced 8.83%	12,424 $1.48 Million
Q2 2024 Jul 18, 2024	BUY	$122.71 - $146.91 $4,785 - $5,729	39 Added 0.29%	13,628 $1.95 Million
Q1 2024 May 02, 2024	SELL	$102.11 - $135.92 $64,737 - $86,173	-634 Reduced 4.46%	13,589 $1.74 Million
Q4 2023 Feb 13, 2024	BUY	$87.78 - $105.45 $17,556 - $21,090	200 Added 1.43%	14,223 $1.47 Million
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $577,469 - $1.27 Million	6,350 Added 82.76%	14,023 $1.28 Million
Q2 2023 Aug 08, 2023	BUY	$155.98 - $172.65 $45,234 - $50,068	290 Added 3.93%	7,673 $1.24 Million
Q1 2023 May 15, 2023	SELL	$132.34 - $159.14 $151,926 - $182,692	-1,148 Reduced 13.46%	7,383 $1.17 Million
Q4 2022 Feb 16, 2023	SELL	$102.55 - $135.33 $12,818 - $16,916	-125 Reduced 1.44%	8,531 $1.15 Million
Q3 2022 Oct 18, 2022	BUY	$95.28 - $116.93 $1,524 - $1,870	16 Added 0.19%	8,656 $862,000
Q2 2022 Jul 20, 2022	SELL	$103.24 - $121.81 $289,794 - $341,920	-2,807 Reduced 24.52%	8,640 $963,000
Q1 2022 May 02, 2022	SELL	$93.1 - $112.54 $100,082 - $120,980	-1,075 Reduced 8.58%	11,447 $1.27 Million
Q4 2021 Feb 11, 2022	BUY	$95.88 - $117.08 $876,726 - $1.07 Million	9,144 Added 270.69%	12,522 $1.4 Million
Q3 2021 Oct 22, 2021	SELL	$84.42 - $106.62 $829,004 - $1.05 Million	-9,820 Reduced 74.41%	3,378 $324,000
Q2 2021 Jul 29, 2021	BUY	$67.66 - $84.76 $4,533 - $5,678	67 Added 0.51%	13,198 $1.11 Million
Q1 2021 May 05, 2021	BUY	$67.06 - $75.82 $654,036 - $739,472	9,753 Added 288.72%	13,131 $885,000
Q1 2020 Apr 30, 2020	SELL	$49.46 - $64.78 $523,583 - $685,761	-10,586 Reduced 75.81%	3,378 $203,000
Q4 2019 Feb 12, 2020	SELL	$49.86 - $58.26 $49 - $58	-1 Reduced 0.01%	13,964 $806,000
Q3 2019 Nov 12, 2019	BUY	$47.54 - $53.43 $663,896 - $746,149	13,965 New	13,965 $723,000

Others Institutions Holding NVO

# of Institutions

1,954

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $232B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsb Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gsb Wealth Management, LLC with notifications on news.

Account

Gsb Wealth Management, LLC Novo Nordisk A S Transaction History